U.S. Markets closed

Nemaura Medical Inc. Announces $8 million Senior Debt Facility Provided by Existing Investors

Loughborough, England, Aug. 01, 2019 (GLOBE NEWSWIRE) --  Nemaura Medical, Inc. (NMRD), a medical technology company focused on the commercialization of SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by diabetics and pre-diabetics, today announced an $8 million (USD) senior credit facility from existing major shareholders, with the first $3.5 million available immediately, to help fund the Company’s European commercial launch plans.  The non-dilutive credit facility will carry 8% interest with quarterly payments and the principal due only upon maturity in 5 years.  The credit facility has no stock, warrants, or equity related instruments, or other associated expenses.

Dr. Faz Chowdhury, CEO of Nemaura, stated, “Nemaura is at an exciting inflection point, having recently received CE Mark approval for SugarBEAT®, the world’s first non-invasive, needle-free, continuous glucose monitor.  We recently submitted a De Novo 510(k) medical device application to the U.S. Food and Drug Administration for SugarBEAT®. We are now aggressively entering the commercialization phase in Europe and other markets, and access to these non-dilutive funds will allow us to accelerate our commercialization timelines.  The CGM market is experiencing rapid growth as larger segments of the diabetic market have started to adopt CGM. We believe SugarBEAT® has distinct advantages as it does not puncture the skin to insert a sensor filament inside the skin and instead the sensor sits on the surface of the skin. The sensor can be worn daily or intermittently, as desired by the user, allowing us to offer a highly competitive product and target both the diabetic (insulin and non-insulin dependent) and pre-diabetic markets.  In addition, we plan to target the wearable health tech and digital health markets, which are both experiencing explosive growth. Overall, we estimate the total addressable market to be roughly $179 billion, many times larger than the market addressable by the current competition.  The willingness of several of our long-term investors to provide this debt facility at very favorable terms to the Company further validates our confidence in the outlook for SugarBEAT® and the tremendous market potential.”

About Nemaura Medical, Inc.:

Nemaura Medical, Inc. (NMRD), is a medical technology company commercializing SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) designed to help people with diabetes and pre-diabetics better manage their glucose levels by spending more time in range.  Insulin users can adjunctively use SugarBEAT® when calibrated by a finger stick reading. SugarBEAT® consists of a daily, disposable adhesive skin-patch connected to a small form factor rechargeable transmitter, connected via Bluetooth to a specially designed mobile application, which displays glucose readings at five-minute intervals throughout the day.

For more information visit:

www.NemauraMedical.com

www.SugarBEAT.com

Cautionary Statement Regarding Forward Looking Statements:

The statements in this press release that are not historical facts, and may constitute forward-looking statements that are based on current expectations and are subject to risks and uncertainties that could cause actual future results to differ materially from those expressed or implied by such statements. Those risks and uncertainties include, but are not limited to, risks related to regulatory approvals and the success of Nemaura’s ongoing studies, including the safety and efficacy of Nemaura’s SugarBEAT® system, the failure of future development and preliminary marketing efforts, Nemaura’s ability to secure additional commercial partnering arrangements, risks and uncertainties relating to Nemaura and its partners’ ability to develop, market and sell SugarBEAT®, the availability of substantial additional equity or debt capital to support its research, development and product commercialization activities, and the success of its research, development, regulatory approval, marketing and distribution plans and strategies, including those plans and strategies related to SugarBEAT®. These and other risks and uncertainties are identified and described in more detail in Nemaura’s filings with the Securities and Exchange Commission, including, without limitation, its Annual Report on Form 10-K for the current year, its Quarterly Reports on Form 10-Q, and its Current Reports on Form 8-K. Nemaura undertakes no obligation to publicly update or revise any forward-looking statements.

Contact:

Crescendo Communications, LLC
212-671-1021
NMRD@crescendo-ir.com


  • Here's When You Should Buy Stocks Again
    Business
    TheStreet.com

    Here's When You Should Buy Stocks Again

    The S&P 500 kicked off the week Monday by gapping down 2.4%, the worst opening gap lower for the broad index since 1982. And it's followed up with consistent selling, putting the broad market on track for its worst week since the financial crisis of 2008. Is this finally the end of the rally that's propelled stocks more than 80% higher on a total-return basis over the past four years?

  • Stock market live updates: Stock futures climb after historic rout; coronavirus fears persist
    Business
    Yahoo Finance

    Stock market live updates: Stock futures climb after historic rout; coronavirus fears persist

    On Thursday evening shortly after 6 p.m. ET, Dow futures (YM=F) were down 0.3%, S&P futures (ES=F) were down 0.4%, and Nasdaq futures (NQ=F) were down 0.3%. “Global markets were down $1.83 trillion today, with the U.S. down $1.33 trillion,“ S&P Dow Jones' Howard Silverblatt said in an email.

  • Coronavirus fears spook stocks: Here's how to keep a cool head and protect your 401(k)
    Business
    USA TODAY

    Coronavirus fears spook stocks: Here's how to keep a cool head and protect your 401(k)

    Sign up here Here are four moves experts say could help protect your investments during volatile periods, such as the bumpy stretch caused by the coronavirus: 401(k): Coronavirus fears shouldn't stop you from investing in stocks Monitoring markets: Dow jumps 300 points as investors assess economic fallout from virus 1. Review your investments Pay attention to where you're invested and which companies are most likely to be affected, portfolio managers say. Daniel Milan, managing partner at Southfield, Michigan-based Cornerstone Financial Services, says the effects from the virus outbreak on the stock market will be short-lived and has cautioned his clients to not let fear drive their investme...

  • Stock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in history
    Business
    Yahoo Finance

    Stock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in history

    Global financial markets plunged for the sixth consecutive day on Thursday, with coronavirus fears shaving over 1,100 points off the Dow (^DJI) — its biggest in history — and sending the S&P 500 (^GSPC) swooning to its fastest-ever correction. Global markets were down $1.83 trillion today, with the U.S. down $1.33 trillion,“ S&P Dow Jones' Howard Silverblatt said in an email. He added that over the past six days, global markets erased $6 trillion in wealth with U.S. markets losing $4 trillion.

  • Something 'dangerous' is happening beneath the surface of the market selloff
    Business
    Yahoo Finance

    Something 'dangerous' is happening beneath the surface of the market selloff

    So every time stocks went up, bonds tailed off and vice-versa,” Academy Securities' Peter Tchir said on Yahoo Finance's The Final Round. All of a sudden, that behavior changed a little bit into the close yesterday. And making it even more dangerous to me, you saw oil fall off into the close.

  • Wait for these signals to buy coronavirus-battered stocks, says BNY Mellon strategist
    Business
    MarketWatch

    Wait for these signals to buy coronavirus-battered stocks, says BNY Mellon strategist

    Some believe the next big fall in equities will come when we see a cluster of U.S. cases, which may partly explain why that popular past time of buying stocks on any dip seems less popular lately. Citigroup strategists are advising against buying equities right now, on the view that if a Federal Reserve lifeline is coming, it may not happen right away. Gov. Warsh argues for immediate, globally coordinated rate cut Our call of the day comes from BNY Mellon's chief strategist Alicia Levine, who has advice for those wanting to know when to buy beaten-down (and down) stocks.

  • Business
    Bloomberg

    How to Tell When Markets Finally Reach a Bottom

    Or, when current Federal Reserve Chair Jerome Powell made his “dovish pivot” in January 2019 by saying the central bank would be “patient and flexible” when it came to considering future interest-rate increases. But what makes the current plunge different is that it's being driven by an event — the threat that the coronavirus will become worldwide pandemic — that is out of the control of monetary policy makers and Wall Street. So, there is unlikely to be some “magic” headline that scrolls across the computer screens of investors and traders that says it is over.

  • Trading halted on TSX, citing order entry issue
    Business
    Yahoo Finance Canada

    Trading halted on TSX, citing order entry issue

    Trading on the TSX and TMX's other exchanges has been halted for the rest of the day as TMX investigates an order entry problem on its exchanges. A technical halt has been declared on TSX, TSXV & TSX Alpha,” said TMX in a statement posted to Twitter. In order to allow Participants to manage their orders, the market will remain in a Pre-Open state until further notice.

  • What to watch in the markets: Friday, February 28
    Business
    Yahoo Finance Video

    What to watch in the markets: Friday, February 28

    After yet another volatile day of trading on Wall Street, Yahoo! Finance's Myles Udland discusses what to watch in the markets tomorrow,

  • Stock-market plunge ‘starting to feel a bit ridiculous,’ but don’t argue, says chart-watcher
    Business
    MarketWatch

    Stock-market plunge ‘starting to feel a bit ridiculous,’ but don’t argue, says chart-watcher

    It doesn't pay to fight the tape, but the stock market could be poised for a big-time rally once the current selloff subsides, a veteran chart-watcher said Thursday. “This move lower is starting to feel a bit ridiculous, but we try not to argue with Ms. Market,” said Mark Arbeter, president of Arbeter Investments, in a note. “If and when this thing turns, we should see some rip-roaring rally.”

  • These stocks have been crushed since the coronavirus began to take down the U.S. market
    Business
    MarketWatch

    These stocks have been crushed since the coronavirus began to take down the U.S. market

    a href="https://www.marketwatch.com/story/these-stocks-have-been-crushed-since-the-coronavirus-began-to-take-down-the-us-market-2020-02-27? siteid=yhoof2" (DVN) Oil & Gas Production -31.0% -39.7% -55.7% 15.2% Royal Caribbean Cruises Ltd.

  • Dow Jones Futures Fall Sharply As Coronavirus Stock Market Correction Intensifies; Tesla, Nvidia, Beyond Meat Down Late
    Business
    Investor's Business Daily

    Dow Jones Futures Fall Sharply As Coronavirus Stock Market Correction Intensifies; Tesla, Nvidia, Beyond Meat Down Late

    Dow Jones futures fell sharply in volatile action Thursday, along with S&P 500 futures and Nasdaq futures. The coronavirus stock market correction intensified Thursday, with the Dow Jones and other major indexes all falling more than 4%. The U.S. is monitoring thousands of people in California for possible Covid-19 infections, while coronavirus cases continued to spread.

  • Beyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'
    Business
    Yahoo Finance

    Beyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'

    The company notched blistering sales growth in its retail (198%) and food service/restaurant segments (223%). Unclear if analysts will ding Beyond Meat for slowing sales growth at each segment compared to the third quarter. Beyond Meat founder and CEO Ethan Brown tells Yahoo Finance the quarter was “outstanding.”

  • Protective Mask Maker Soars 340% This Week As Coronavirus Spirals
    Business
    Investor's Business Daily

    Protective Mask Maker Soars 340% This Week As Coronavirus Spirals

    Alpha Pro Tech announced a spike in face mask orders amid the spiraling coronavirus outbreak, a day after disclosing earnings for the fourth quarter. APT stock soared, also boosting Lakeland Industries and Dow Jones Industrial Average component 3M. APT said Thursday it has booked about $14.1 million face mask orders since Jan. 27. That is up from the $10.4 million APT had reported just two weeks ago on Feb. 13.

  • Business
    TheStreet.com

    Jim Cramer on Coronavirus: What It Means for Markets, Federal Reserve and Microsoft

    Jim Cramer has some thoughts on the markets, the Federal Reserve and Microsoft as coronavirus fears shake Wall Street. Stock futures declined sharply Thursday, putting Wall Street on pace for its worst week since the global financial crisis in 2008, as coronavirus infections accelerated and health officials confirmed that a California man contracted the disease despite having no travel links or contacts with those afflicted by the virus. The company warned investors that it will fall short of previously issued fiscal third-quarter sales guidance of between $10.75 billion and $11.15 billion for its "more personal computing" segment, which includes Windows OEM and Surface.

  • Trump talks about the stock market, and gets 1 out of 3 points right
    Business
    MarketWatch

    Trump talks about the stock market, and gets 1 out of 3 points right

    Stock markets do this all the time. Since Trump was elected president in November 2016, the Dow has risen from around 18,000 to around 27,000. Trump went on an extended riff blaming the market's fall on Tuesday's Democratic presidential debate.

  • Trending Ticker: VIR Surges as Coronavirus fears persist
    Business
    Yahoo Finance Video

    Trending Ticker: VIR Surges as Coronavirus fears persist

    As the markets continue to fall, the biotech field is seeing a boost as companies race to develop vaccines and a cure. Vir Biotechnology Inc. shares surged over 60%, while Gilead Sciences stocks saw a bump of 4%.

  • 'What's Going On, Moderna?' Investors Ask As Shares Go On A Wild Ride
    Business
    Investor's Business Daily

    'What's Going On, Moderna?' Investors Ask As Shares Go On A Wild Ride

    Moderna took biotech investors on a ride Thursday as MRNA stock rocketed, was halted and then plunged in a matter of hours. On the stock market today, MRNA stock toppled 10.3%, to 26.16. But in the early morning, shares of the biotech company skyrocketed more than 23% to a fresh high at 36.

  • Business
    Barrons.com

    Fear Has Overtaken This Market. How to Use It to Turn a Profit.

    In anticipation, the stock market has experienced some of its most dramatic losses in two years. The profound rotation away from risk assets into Treasury bonds earlier this week should be considered as a warning shot across the equity market's bow. Early next week, the Institute for Supply Management will release its February report on U.S. economic activity, and similar reports will be released that measure economic activity all over the world.

  • Business
    GuruFocus.com

    Battered Energy Stocks Are Now Alluring

    APA 30-Year Financial Data The intrinsic value of APA Peter Lynch Chart of APA With all the bad news that has plagued the industry for the past several years, what makes the sector so attractive currently? Who in their right mind would want put their money in these companies, whose shares have been heading on a persistent downwards trajectory for over the past five years? Precisely becasue of the difficult times suffered by the energy stocks over the past few years, there is now a noticeable disconnect between energy and the overall market, which ascended to new highs recently while the battering of the trailing energy sector continued.

  • Coronavirus just sent the Dow crashing 1,100 points and it could get worse
    Business
    Yahoo Finance

    Coronavirus just sent the Dow crashing 1,100 points and it could get worse

    The disturbing coronavirus driven selloff across global stock markets this week may be the tip of the iceberg for one simple reason. Stocks have yet to price in a mild — or somewhat bruising — recession in the U.S. as coronavirus infection cases pile up and bring consumer activity and businesses to a standstill. Up until now, equity strategists Yahoo Finance have talked with, say the stock market's six-day drubbing largely reflects de-leveraging by hedge funds and speculators on momentum names (see Microsoft, Apple, etc.).

  • Dow Jones Suffers 3,239-Point Weekly Drop; These 3 Growth Stocks Deliver Sell Signals
    Business
    Investor's Business Daily

    Dow Jones Suffers 3,239-Point Weekly Drop; These 3 Growth Stocks Deliver Sell Signals

    The Dow Jones Industrial Average continued to get hammered in the stock market correction, and in late-afternoon trade the 30-stock blue chip index marked a new session low of 25,753. The Dow Jones fell well more than 3%. Former Federal Reserve Chair Janet Yellen reportedly commented at an event in Michigan that coronavirus has the potential to pull the U.S. economy into recession.

  • A Rumored Gilead Takeover Offer Sent This Biotech Stock Flying
    Business
    Investor's Business Daily

    A Rumored Gilead Takeover Offer Sent This Biotech Stock Flying

    Shares of Forty Seven popped Thursday on a report Gilead Sciences approached the cancer-focused biotech company with a takeover deal. In after-hours trading on the stock market today, Forty Seven stock jumped 23.5%, near 60.25. Gilead stock also rose 1.3%, near 73.60.

  • Business
    Barrons.com

    GE Stock Has Dropped for 10 Straight Days. Here’s What Is Going On.

    Stock in iconic American manufacturer (GE) is getting hammered in the coronavirus-related stock market selloff. Shares are at about $10.89, down 6 cents or 0.6% in midday trading Thursday. That may not sound like much for any given day, but shares have fallen for 10 consecutive trading sessions, losing 17.3% over that span.

  • Warren Buffett Bets on These 3 High-Yield Dividend Stocks
    Business
    TipRanks

    Warren Buffett Bets on These 3 High-Yield Dividend Stocks

    It hasn't escaped notice, however, that the sudden hit to the market has occurred just as Senator Bernie Sanders, an avowed socialist with a vigorous anti-Wall Street policy platform, has taken a commanding lead in the race for the Democratic Party Presidential election nomination. Any strong defensive investing strategy will include dividends. Warren Buffett, certainly no stranger to smart investing, is long-term fan of dividend investing, as a look at Berkshire Hathaway's holdings shows.